News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Mergers and Acquisitions
DrugDev Acquires Award-Winning Trialnetworks Platform, Launches Innovation Lab, Unveils Investigator Databank Website And Reaches $1 Billion In Global Site Payments In First Half Of 2014 8/21/2014
Pfizer Inc. (PFE) Eyes Possible Actavis (ACT) Bid Whilst Weighing Next Steps Over AstraZeneca PLC (AZN) 8/21/2014
Mylan Inc. (MYL) Makes Second Round Of Bidding For GlaxoSmithKline (GSK) Drug Portfolio 8/21/2014
Clinigen Group Further Strengthens Oncology Support Portfolio With Acquisition Of Ethyol® (Amifostine), From AstraZeneca PLC (AZN) 8/20/2014
Allergan Inc. (AGN) Approaches Salix Pharmaceuticals, Ltd. (SLXP) To Fend Off Valeant Pharmaceuticals International (VRX)'s Hostile Bid 8/20/2014
Pozen, Inc. (POZN) Announces U.S. Rights For TREXIMET® Have Been Acquired By Pernix Therapeutics, Inc. (PTX) 8/20/2014
Sweden's Recipharm AB Pays $160 Million For Corvette Pharmaceutical Services Group 8/19/2014
Cubist Pharmaceuticals, Inc. (CBST) Could Be An Acquisition Target For Needy Pfizer Inc. (PFE) 8/19/2014
Confirmed: Novartis AG (NVS) To Invest In Gamida Cell Ltd., Could Buy Out Company In $635 Million Cancer Deal 8/19/2014
Conflicting Reports Surface Over Roche Holding AG (RHHBF.PK)'s $10 Billion Deal, Chugai Pharmaceutical Co., Ltd. (Japan) Denies Talks 8/19/2014
Pharming Group (PHGUF.PK) Acquires New Product Leads Through The Acquisition Of Certain Assets Of TRM SASU For € 0.5 Million In Cash 8/19/2014
Salix Pharmaceuticals, Ltd. (SLXP) Announces Early Termination Of HSR Waiting Period For Pending Transaction 8/19/2014
Deal Is Back On: Novartis AG (NVS) To Invest Heavily In Gamida Cell Ltd. Before Acquisition 8/18/2014
InterMune, Inc. (ITMN) Goes Up On The Block; GlaxoSmithKline (GSK), Roche (RHHBY), Sanofi (France) (SAN.PA) Line Up 8/18/2014
GTCR Completes Acquisition Of Cole-Parmer Instrument Company 8/18/2014
Valeant Pharmaceuticals International (VRX) Extends Offer To Acquire Allergan Inc. (AGN) 8/18/2014
Roche (RHHBY) May Gobble Up The Rest Of Chugai Pharmaceutical Co., Ltd. (Japan) For $10 Billion 8/15/2014
Mallinckrodt Pharmaceuticals (MNK) Completes Acquisition Of Questcor Pharmaceuticals, Inc. (QCOR) 8/15/2014
SEC Investigating Valeant Pharmaceuticals International (VRX), Pershing Square's Hostile Takeover Bid For Allergan Inc. (AGN) 8/15/2014
Allergan Inc. (AGN) Grabs TARIS Biomedical's Lead Program In Deal Worth $587.5 Million 8/14/2014
Merck KGaA (MKGAF.PK) CEO Eyes Interesting Takeover Targets 8/14/2014
Mallinckrodt And Questcor Pharmaceuticals, Inc. (QCOR) Shareholders Approve Mallinckrodt's Acquisition Of Questcor 8/14/2014
Miltenyi Biotec, Inc. Acquires Gene Therapy Assets From Lentigen Corporation 8/14/2014
Valeant Pharmaceuticals International (VRX) Receives FTC Second Request Under Hart-Scott-Rodino 8/13/2014
SkyePharma Inc. (SKYE) Acquires A Novel Inhaled Therapy Platform 8/13/2014
uniQure Acquires Cardiology Gene Therapy Company InoCard 8/12/2014
Akorn, Inc. (AKN) Completes Acquisition Of VersaPharm 8/12/2014
Oncothyreon Inc. (ONTY) Announces Acquisition Of Alpine Biosciences 8/12/2014
Boehringer Ingelheim Vetmedica, Inc. Acquires Licensing Rights For Artilysin® Technology From Lysando AG 8/12/2014
DRI Capital Pays Rush University Medical Center $42 Million For AMPYRA® Royalty Rights 8/12/2014
Allergan Inc. (AGN) Receives Second Request From Federal Trade Commission Regarding Valeant Pharmaceuticals International (VRX)’s Unsolicited Acquisition Proposal 8/11/2014
NextSourceCS Acquires Amatheon Compounding Services In An Effort To Help Alleviate The Absence Of Critical Discontinued Drugs In The Veterinary Industry 8/8/2014
AstraZeneca PLC (AZN), Shire Slip As The U.S. Looks To Stop Tax Inversion Deals 8/7/2014
After Layoff News, Novartis AG (NVS)'s New York Campus Officially Goes On The Market 8/7/2014
Advisor ISS Backs Ackman's Call For Allergan Inc. (AGN) Meeting, Event Could Support The Removal Of Directors, Sale To Valeant Pharmaceuticals International (VRX) 8/7/2014
Endo International plc (ENDP) Completes Acquisition Of DAVA Pharmaceuticals 8/7/2014
Sterigenics International, Inc. Completes $826 Million Acquisition Of Nordion Inc. 8/6/2014
Jazz Pharmaceuticals plc (JAZZ) Completes Acquisition Of Rights To Defibrotide In The Americas From Sigma-Tau Pharmaceuticals 8/6/2014
Analysts Believe Vulnerable GlaxoSmithKline (GSK) May Be Pfizer Inc. (PFE)'s Plan B 8/6/2014
Alvogen Pays $187 Million For Korea's Dream Pharma 8/6/2014
The Cooper Companies, Inc. (COO) Completes Acquisition Of Sauflon Pharmaceuticals Inc. And Announces $700 Million 3-Year Term Loan 8/6/2014
Roche (RHHBY) Bags Santaris Pharma A/S In Deal Worth $450 Million 8/5/2014
CIRCADIAN® Acquires A Controlling Stake In ZircLight Inc. With A Series A Investment Led By Ams AG 8/5/2014
The HallStar Company Expands Organics Portfolio With Florasolvs® Natural Esters Acquisition 8/5/2014
Stem Cell Company ReproCELL (Japan) Acquires 3D Cell Culture Company Reinnervate Limited (UK) And Human Tissue Supplier Bioserve (USA) 8/5/2014
Merck & Co., Inc. (MRK) Completes Tender Offer To Acquire Idenix Pharmaceuticals, Inc. (IDIX) 8/5/2014
Cellular Biomedicine Group (CBMG) Announces Acquisition Of Immune Cell Therapy Technology And U.S. Patent 8/4/2014
ANI Pharmaceuticals, Inc. Acquires Vancocin® Capsules And Additional Vancomycin Assets From Shire 8/4/2014
PCI Announces Completion Of Penn Pharmaceutical Services Purchase 8/4/2014
Institutional Shareholder Services Inc. And Glass Lewis Recommend That Shareholders Of Mallinckrodt And Questcor Pharmaceuticals, Inc. (Headquarters) (QCOR) Vote FOR Mallinckrodt's Acquisition Of Questcor 8/4/2014
Nordion Receives Investment Canada Act Approval And Announces Expected Closing Date For Acquisition By Sterigenics 8/4/2014
Closing For Pernix Therapeutics, Inc. (PTX) Transaction To Acquire Treximet® Tablets For Migraine From GlaxoSmithKline (GSK) Delayed 8/4/2014
Private Equity Firms Mull $10 Billion Merger Of Older GlaxoSmithKline (GSK), Sanofi (France) (SAN.PA) Brands 8/4/2014
Hedge Funds Bet AstraZeneca PLC (AZN) Will Stay Independent For A Little While Longer 8/4/2014
As The Pursuit For Allergan Inc. (AGN) Continues, Valeant Pharmaceuticals International (VRX) Hunts For More Deals—Including Contact Lenses 8/1/2014
Regeneron Pharmaceuticals, Inc. (REGN), Sanofi (France) (SAN.PA) Bag BioMarin Pharmaceutical Inc. (BMRN)'s Special FDA Priority Review Voucher For $67.5 Million 8/1/2014
Meda AB (MEDA-A.ST) Bags Rottapharm $3.08 Billion To Create A European Pharma Powerhouse 7/31/2014
Cortice Biosciences Announces Acquisition Of Exclusive Rights To A Novel Neurological Disease Therapeutic And Development Platform 7/31/2014
Pfizer Inc. (PFE)’s Stake In Cellectis (ALCLS)’ Capital Is Welcomed By Its Shareholders 7/31/2014
AstraZeneca PLC (AZN) Scoops Up Almirall Lung Drugs For Up To $2.1 Billion 7/30/2014
Pfizer Inc. (PFE) Grabs Baxter International, Inc. (BAX)'s Portfolio Of Marketed Vaccines For $635 Million 7/30/2014
Pfizer Inc. (PFE) CEO Aggressively Seeking Deals, Leaves Investors Guessing On AstraZeneca PLC (AZN) Intentions 7/30/2014
Tigermed And Frontage Laboratories Complete Strategic Investment Agreement 7/30/2014
Cellectis (ALCLS) Sells Its Swedish Unit To Takara Bio For Undisclosed Amount 7/29/2014
Jin-En International Group Holding Co. Acquires Nascent Biotech Inc. And Changes Name To Nascent Biotech Inc. 7/29/2014
Clinuvel Snags A $95 Million Takeover Bid From New York-Based Retrophin, Inc. (RTRX) 7/28/2014
Welichem Biotech Inc. (WBI.V) Ends Effort To Re-Acquire China Rights To Psoriasis Treatment 7/28/2014
PaxVax, Inc. Acquires FDA-Approved Typhoid Vaccine Vivotif 7/28/2014
Variation Biotechnologies Inc. And Paulson Capital Announce Completion Of Merger 7/28/2014
Rumor: Hospira, Inc. May Buy Danone's Medical-Nutrition Unit For $5 Billion 7/28/2014
PCI Expands Service Offering With Acquisition Of Penn Pharmaceutical Services 7/28/2014
Endo International plc (ENDP) Completes Acquisition Of Grupo Farmaceutico Somar® 7/25/2014
Simulations Plus (SLP) Provides Additional Details Regarding Cognigen Corporation Acquisition 7/25/2014
AbbVie (ABBV) Trod Cautiously In Inversion Takeover Bid To Woo Drug Maker Shire 7/25/2014
Hikma Pharmaceuticals Buys Ben Venue Laboratories's Generic Manufacturing Site 7/24/2014
WIRB-Copernicus Group Announces Acquisition Of Alliance Biosciences; Executives Join WCG Biosafety Division 7/24/2014
Simulations Plus (SLP) To Acquire Cognigen Corporation 7/24/2014
Chromatin, Inc. Acquires Sorghum Production And Supply Company, Production Seeds Plus, Inc. 7/23/2014
Waters Corporation (WAT) Acquires REIMS Technology, Strengthens Health Science Initiative 7/23/2014
Welichem Announces Termination Of Asset Purchase Agreement And Update On Compulsory Acquisition 7/23/2014
Cancer Genetics, Inc. (CGIX) Announces Acquisition Of Gentris Corporation, A Leading Global Pharmacogenomics Company, And Increases Contract Backlog To Over $18 Million 7/22/2014
AbbVie (ABBV) Finally Clinches Shire For $54 Billion 7/21/2014
Roche (RHHBY) CEO Plans To Steer Clear Of Big Acquisitions 7/21/2014
Teva Pharmaceutical Industries Limited (TEVA) Completes Acquisition Of Labrys: Opens Door To A Strong And Novel Migraine Prevention And Treatment Franchise Within Its CNS Portfolio 7/21/2014
Stallergenes, S.A. (GENP.PA) Expands Latin American Presence With Acquisition Of Alergo Pharma S.R.L. In Argentina 7/21/2014
ABL, Inc. Acquires Majority Interest In Platine Pharma Services 7/21/2014
Gentiva Health Services (GTIV) Grabs $634 Million Bid, Rejects Kindred Bio (KIN)'s Stake Offer 7/18/2014
Symplmed Completes Ownership Of Perindopril Franchise With Acquisition Of ACEON® 7/18/2014
Perrigo Co. (PRGO) Mum On Published Merger Rumors, Potential Target For Abbott Laboratories (ABT) 7/17/2014
Pfizer Inc. (PFE) Snags INNOPHARMA In $360 Million Deal 7/17/2014
Thermo Fisher Scientific (TMO) To Sell Cole-Parmer Instrument Company For $480 Million 7/17/2014
Novartis AG (NVS), BWK Sell Stakes In Patch Maker LTS Lohmann Therapie-Systeme AG, Pockets $400 Million From Sale 7/17/2014
Sanofi (France) (SAN.PA) Quietly Held Talks With Abbott Laboratories (ABT), Mylan Inc. (MYL) About Mature Drugs 7/17/2014
Yibai Pharma To Acquire Horus C&K Pharma For $128 Million 7/16/2014
Investor Believes Roche (RHHBY) May Buy Exelixis, Inc. (EXEL) For Skin Cancer Drug 7/16/2014
Shire Ready To Bow To AbbVie (ABBV)'s Increased $53 Billion Offer 7/15/2014
Anthera Pharmaceuticals, Inc. (ANTH) Announces Acquisition Of Sollpura® (liprotamase) For Exocrine Pancreatic Insufficiency From Eli Lilly and Company (LLY) 7/15/2014
Chiltern Acquires Ockham And The Companies Merge Operations 7/15/2014
EPIRUS Biopharmaceuticals And Zalicus Inc. (ZLCS) Complete Merger - Combined Company Will Trade As EPIRUS Biopharmaceuticals 7/15/2014
Phlexglobal Announces Acquisition By Bridgepoint Development Capital 7/15/2014
Hikma Pharmaceuticals Completes The Acquisition Of Assets Of Bedford Laboratories 7/15/2014
Abbott Laboratories (ABT) Unloads Developed Markets Generics Unit To Mylan Inc. (MYL) For $5.3 Billion 7/14/2014
Ventrus Biosciences, Inc.  (VTUS) Becomes Assembly Biosciences As Stockholders Approve Merger With Assembly Pharmaceuticals 7/14/2014
ATS Labs, Inc. Announces the Acquisition Of MicroTest Labs, Inc. 7/14/2014
Lake Consumer Products Acquires License To Bring vH Essentials PMS Relief Product To Market 7/11/2014
BioTie Therapies Corp. Will Not Exercise Option To Buy Neurelis, Neurelis Regains Rights To Intranasal Diazepam Program 7/11/2014
Valeant Pharmaceuticals International (VRX) Completes Sale Of Filler And Toxin Assets To Galderma 7/10/2014
AbbVie (ABBV) Forced To Retract Claims Of Shire Investor Support 7/9/2014
NeoGenomics, Inc. (NGNM.OB) Completes Acquisition Of Path Logic 7/9/2014
MabVax Therapeutics, Inc. And Telik, Inc. (TELK) Announce Closing Of Merger 7/9/2014
Salix Pharmaceuticals, Ltd. (SLXP) Scoops Up Cosmo Technologies For Tax Savings 7/9/2014
Baxter International, Inc. (BAX) Snags Orphan Drug-Focused Biopharma, AesRx For Undisclosed Amount 7/9/2014
Easton Pharmaceuticals (OP: EAPH) Announces Closing Of Agreement To Invest And Acquire Ownership Interest In AMFIL Technologies Inc. And The mPACT -GROzone Antimicrobial Systems Line Of Products 7/8/2014
Mariel Therapeutics Announces Definitive Agreement To Acquire Stryker Corporation  (SYK)'s BMP-7 Assets For Potential Use In Osteoarthritis And Organ Fibrosis 7/8/2014
$100 Million Triple Life Sciences Deal For Newly Formed Concept Life Sciences 7/8/2014
Valeant Pharmaceuticals International (VRX) Completes Acquisition Of PreCision Dermatology 7/8/2014
StoneCalibre Acquires Nucleic Acid Purification Products Manufacturer Edge BioSystems, Inc. 7/8/2014
AbbVie (ABBV)'s Battle For Shire: Why This Time It's Different 7/8/2014
Sarepta Therapeutics (SRPT) Quietly Buys Eisai Company, Ltd. (ESALY.PK)'s Vacant R&D Lab In Cambridge For $25 Million 7/7/2014
AbbVie (ABBV) To Dispatch Research Chief Jim Sullivan To London 7/7/2014
Merus Labs International Inc. Agrees To Buy Dacha Strategic Metals Inc. 7/7/2014
Hospira, Inc. Completes Acquisition Of Orchid Chemicals & Pharmaceuticals Ltd.'s Active Pharmaceutical Ingredient Manufacturing And R&D Facility 7/7/2014
Genentech (RHHBY) To Pay Up To $1.7 Billion For San Diego Biotech Firm Seragon Pharmaceuticals 7/7/2014
Jazz Pharmaceuticals plc (JAZZ) Wagers Up To $250 Million On Rare Disease Drug From Sigma-Tau Pharmaceuticals 7/3/2014
Bio-Techne Snags Novus Biologicals For $60 Million Cash 7/3/2014
IMPAX Laboratories, Inc. (IPXL) Acquires Two Products From Actavis (ACT) 7/3/2014
NicOx SA (COX.PA) Scoops Up Aciex Therapeutics In $120 Million Deal 7/2/2014
PAREXEL International (PRXL) Announces Acquisition Of ATLAS Medical Services, A Provider Of Clinical Research Services In Turkey 7/2/2014
Actavis (ACT) Announces Final Stockholder Merger Consideration Election Results In Connection With Forest Laboratories, Inc. (FRX) Acquisition 7/2/2014
Integrated DNA Technologies Acquires SURVEYOR® Nuclease Business From Transgenomic, Inc. (TBIO) 7/2/2014
Quintiles, Inc. (Q) Completes Acquisition Of Encore Health Resources 7/2/2014
Furiex Pharmaceuticals, Inc. (FURX) Stockholders Approve Acquisition By Actavis (ACT); Ukrainian Antimonopoly Committee Clears Proposed Merger 7/2/2014
Intrexon Corporation To Acquire Trans Ova Genetics 7/2/2014
Massachusett's bluebird bio (BLUE) Snaps Up Pregenen For Up To $139.9 Million 7/2/2014
Bay Area's Transcept Pharmaceuticals, Inc. (TSPT) Soars On Plans To Merge With Paratek Pharmaceuticals, Inc., Picks Up $93 Million Along The Way; Transcept Stock Up +19.60% At Market Close (July 1, 2014) 7/1/2014
Johnson & Johnson (JNJ) Completes Divestiture Of Ortho-Clinical Diagnostics To The Carlyle Group 7/1/2014
Welichem Responds To Completion Of Take-Over Bid 7/1/2014
Actavis (ACT) And Forest Laboratories, Inc. (FRX) Receive U.S. FTC Clearance For Actavis' Proposed Acquisition Of Forest 7/1/2014
Actavis (ACT) Completes Forest Laboratories, Inc. (FRX) Acquisition 7/1/2014
ANI Pharmaceuticals, Inc. Buys Lithobid Extended Release Tablets From Noven Therapeutics For $12 Million 7/1/2014
AbbVie (ABBV) Takes Shire Courtship Trip To London 6/30/2014
Merz North America Pays $600 Million For Ultrasound Facelift Company Ulthera 6/30/2014
RedHill Biopharma Ltd. (RDHL) Acquires Phase 2 Oncology Drug MESUPRON® From Wilex AG (WL6.DE) 6/30/2014
Actavis (ACT) And Forest Laboratories, Inc. (FRX) Announce Preliminary Stockholder Merger Consideration Election Results 6/30/2014
BioAlliance Pharma And TopoTarget A/S Shareholders Approve Proposed Cross-Border Merger To Create Onxeo 6/30/2014
Big Investor Picks Up Large Stake In Allergan Inc. (AGN) To Push For Valeant Pharmaceuticals International (VRX) Merger 6/27/2014
Shire Entertained Many "Large Opportunities" Before AbbVie (ABBV) Bid 6/27/2014
Like GlaxoSmithKline (GSK), Sanofi (France) (SAN.PA) Mulls Sale Of Older Drugs, Plans To Put Dengue Vaccine Program In Separate Unit 6/27/2014
AmerisourceBergen Corporation (ABC) Completes Acquisition Of Minority Interest In Profarma Distribuidora de Produtos Farmacêuticos S.A. 6/27/2014
Auxilium Pharmaceuticals (AUXL) To Merge With Canadian Biotech QLT Inc. (QLTI) 6/26/2014
Shire Pharmaceuticals (SHPG) Release: We Believe The Bids Could Go Higher, Or A Different Currency Is Required 6/25/2014
Shire Comments On AbbVie (ABBV)’s Unchanged Proposal 6/25/2014
AbbVie (ABBV) Urges Talks With Shire, May Have To Raise Bid To $51 Billion 6/25/2014
Valeant Pharmaceuticals International (VRX) Files Preliminary Proxy Statement For Special Meeting Of Shareholders To Approve Share Issuance In Proposed Acquisition Of Allergan Inc. (AGN) 6/25/2014
Warnex Inc. (CC:WNX) Received TSX-V Approval And Waives Due Diligence Condition To Amalgamation With Diagnos Inc. (ADK) 6/25/2014
Zalicus Inc. (ZLCS) And EPIRUS Biopharmaceuticals Agree Zalicus Stockholders To Own 19 Percent Of Combined Company Post-Merger 6/25/2014
Shire To Set Out AstraZeneca PLC (AZN)-Style Defense Against AbbVie (ABBV)'s $46 Billion Bid 6/24/2014
Endo Buys DAVA Pharmaceuticals For $575 Million 6/24/2014
H. Lundbeck A/S (LUN.CO) Completes Acquisition Of Chelsea Therapeutics, Inc. (CHTP) 6/24/2014
Actavis (ACT) And Forest Laboratories, Inc. (FRX) Announce Tentative Election Deadline Of June 27, 2014 6/24/2014
Abbott Laboratories (ABT) Scoops Up Russian Drugmaker Veropharm For Between $395 To $495 Million Cash 6/24/2014
Questcor Pharmaceuticals, Inc. (Headquarters) (QCOR) Closes Transaction To Acquire International Rights To Synacthen® And Synacthen® Depot 6/23/2014
AbbVie (ABBV) Release: Shire Bid Could Move A Lot High Risk Puts Ceiling At £55/Share 6/23/2014
Valeant Pharmaceuticals International (VRX) Posts Fact-Based Answers To Refute Allergan's Misleading Statements 6/23/2014
Lundbeck Inc. (LUN.CO) Successfully Completes Tender Offer For Chelsea Therapeutics, Inc. (CHTP) 6/23/2014
Albany Molecular Research, Inc. (AMRI) (AMRI) Announces Early Termination Of HSR Waiting Period For Acquisition Of OSO BioPharmaceuticals Manufacturing, LLC 6/23/2014
Emdeon Corporation (HLTH) To Acquire Capario To Enhance Its Revenue Management Platform 6/23/2014
Merger Of Simbec & Orion Corporation To Create A New International Full-Service CRO 6/23/2014
Allergan Inc. (AGN) Board Of Directors Unanimously Rejects Unsolicited Exchange Offer From Valeant Pharmaceuticals International (VRX) 6/23/2014
Shire plc Release: Management Spurns Three Offers From AbbVie (ABBV) , Fighting For Irish Independence, Call Monday Morning 6/23/2014
To Fend Off Pfizer Inc. (PFE), AstraZeneca PLC (AZN) Contemplating Sale Of Some Future Revenue From Existing Drugs 6/23/2014
Third Time Is Not The Charm As AbbVie (ABBV)'s $46 Billion Bid For Irish Rival Shire Rejected 6/23/2014
Cancer Genetics, Inc. (CGIX) Scoops Up Gentris Corporation In $4.75 Million Deal 6/23/2014
Celsion Corporation (CLN) Completes Acquisition Of EGEN, Inc. 6/20/2014
Rumor: Pfizer Inc. (PFE) May Be Interested In Buying Bristol-Myers Squibb Company (BMY) After Losing AstraZeneca PLC (AZN) 6/20/2014
Akorn, Inc. (AKN) Divests ECR Pharmaceuticals To Valeant Pharmaceuticals International (VRX) For $41 Million Cash 6/20/2014
Merck & Co., Inc. (MRK) Begins Tender Offer To Acquire Idenix Pharmaceuticals, Inc. (IDIX) 6/20/2014
While Valeant Pharmaceuticals International (VRX) Fights For Allergan Inc. (AGN), Allergan Takeover Bid For Shire "Imminent" 6/19/2014
New Drugs To Help Maintain Independence, Ward Off M&A Prospects: Actelion Ltd. (ALIOF.PK) CEO 6/19/2014
Allergan Inc. (AGN) Board Of Directors To Review Unsolicited Exchange Offer From Valeant Pharmaceuticals International (VRX) 6/18/2014
Actavis (ACT) And Forest Laboratories, Inc. (FRX) Shareholders Approve Proposals Related To Actavis' Planned Acquisition Of Forest 6/18/2014
Irish-Based Shire Braces For Takeover Bids 6/18/2014
MRC Technology Sells Its Melanocortin Receptors Programme To Pfizer Inc. (PFE) 6/18/2014
Allergan Inc. (AGN) Releases Personal Emails From Morgan Stanley (MST) Calling Valeant Pharmaceuticals International (VRX) A "House Of Cards" 6/18/2014
BioClinica, Inc. Acquires Blueprint Clinical, Inc. 6/16/2014
Merck & Co., Inc. (MRK) Open To More Biotech Deals After Idenix Pharmaceuticals, Inc. (IDIX): Research Chief 6/16/2014
Pfizer Inc. (PFE) CFO Reveals Money Killed AstraZeneca PLC (AZN) Deal 6/16/2014
AbbVie (ABBV) And Johnson & Johnson (JNJ) Were In A Bidding War For Idenix Pharmaceuticals, Inc. (IDIX), Will Achillion Pharmaceuticals, Inc. (ACHN) Be The Next Target? 6/13/2014
In Bid For Allergan Inc. (AGN), Valeant Pharmaceuticals International (VRX) Defends Its Record On Research 6/12/2014
Hyperion Therapeutics Completes Acquisition Of Andromeda Biotech 6/12/2014
Commentary: BioSpace (DHX) Readers Sound Off On Big Pharma Takeovers 6/12/2014
Roche (RHHBY) Markets 5 Buildings On New Jersey Campus, Razing The Rest 6/11/2014
Can Pfizer Inc. (PFE) Curb Its Appetite For Big Acquisitions? 6/11/2014
Spotlight Innovation Subsidiary Celtic Biotech Iowa, Inc. Completes Merger With Celtic Biotech Ltd. 6/11/2014
Merck & Co., Inc. (MRK) Snags Cambridge's Idenix Pharmaceuticals, Inc. (IDIX) For $3.85 Billion 6/11/2014
Activist Investor Ackman Says Allergan Inc. (AGN) Investors Back Takeover At $180 A Share 6/10/2014
Celsion Corporation (CLN) Scoops Up Privately-Held EGEN For $14 Million Including Debts 6/10/2014
NovaDigm Therapeutics Strengthens Candida Vaccine Portfolio With Three New Antigens Via Series Of Rights Acquisitions 6/10/2014
Chelsea Therapeutics, Inc. (CHTP) Announces The Expiration Of The Hart-Scott-Rodino Waiting Period In Relation To The Proposed Acquisition Of Chelsea Therapeutics By H. Lundbeck A/S (LUN.CO) 6/6/2014
VWR International, Inc. Acquires LABREPCO, Inc. 6/4/2014



//-->